$300 | Single User
$600 | Site License
$900 | Global License

Gene Techno Science Co Ltd (4584) - Financial and Strategic SWOT Analysis Review [Report Updated: 09-03-2018]

Published by Global Data: 09 Mar 2018 | 196387 | In Stock

Introduction

Summary

Gene Techno Science Co Ltd (GTS) is a developer and marketer of drug and antibodies for cancer, intractable diseases and rare diseases. The company develops biological and biosimilar products. Its biological pipeline products include GND-001 for immunological disease and oncology; GND-004, for oncology; and GND-007 for immunological disease. GTS also develops biosimilar products, which include GBS-008 for infectious disease; GBS-010 for oncology; and GBS-011 for renal disease. GTS’ primary product granulocyte colony stimulating factor (G-CSF) promotes the differentiation and growth of neutrophils, one of the white blood cells, and increases neutrophils’ function. It conducts research and development of new biopharmaceuticals collaborating with universities and research institutions. The company has operations in Osaka, Sapporo, and Tokyo. GTS is headquartered in Sapporo, Japan.

This comprehensive SWOT profile of Gene Techno Science Co Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Gene Techno Science Co Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – Analyst’s summarization of the company’s business strategy.

- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Table of Contents
for Gene Techno Science Co Ltd (4584) - Financial and Strategic SWOT Analysis Review [Report Updated: 09-03-2018]

  • Table of Contents

    Section 1 - About the Company

    Gene Techno Science Co Ltd - Key Information

    Gene Techno Science Co Ltd - Overview

    Gene Techno Science Co Ltd - Key Employees

    Gene Techno Science Co Ltd - Key Employee Biographies

    Gene Techno Science Co Ltd - Key Operational Heads

    Gene Techno Science Co Ltd - Major Products and Services

    Gene Techno Science Co Ltd - History

    Gene Techno Science Co Ltd - Company Statement

    Gene Techno Science Co Ltd - Locations And Subsidiaries

    Gene Techno Science Co Ltd - Key Manufacturing facilities

    Head Office

    Other Locations & Subsidiaries

    Section 2 - Company Analysis

    Gene Techno Science Co Ltd - Business Description

    Gene Techno Science Co Ltd - Corporate Strategy

    Gene Techno Science Co Ltd - SWOT Analysis

    SWOT Analysis - Overview

    Gene Techno Science Co Ltd - Strengths

    Gene Techno Science Co Ltd - Weaknesses

    Gene Techno Science Co Ltd - Opportunities

    Gene Techno Science Co Ltd - Threats

    Gene Techno Science Co Ltd - Key Competitors

    Section 3 - Company Financial Performance Charts

    Gene Techno Science Co Ltd - Financial Ratios

    Financial Ratios - Capital Market Ratios

    Financial Ratios - Annual Ratios

    Financial Ratios - Interim Ratios

    Financial Ratios - Ratio Charts

    Section 4 - Appendix

    Appendix

    Methodology

    Ratio Definitions

    About GlobalData

    Contact Us

    Disclaimer

    Note*: Some sections may be missing if data is unavailable for the company

List Of Tables
in Gene Techno Science Co Ltd (4584) - Financial and Strategic SWOT Analysis Review [Report Updated: 09-03-2018]

List of Tables


Gene Techno Science Co Ltd, Key Information

Gene Techno Science Co Ltd, Key Ratios

Gene Techno Science Co Ltd, Share Data

Gene Techno Science Co Ltd, Major Products and Services

Gene Techno Science Co Ltd, History

Gene Techno Science Co Ltd, Key Employees

Gene Techno Science Co Ltd, Key Employee Biographies

Gene Techno Science Co Ltd, Key Operational Heads

Gene Techno Science Co Ltd, Other Locations

Gene Techno Science Co Ltd, Subsidiaries

Gene Techno Science Co Ltd, Key Manufacturing facilities

Gene Techno Science Co Ltd, Key Competitors

Gene Techno Science Co Ltd, SWOT Analysis

Gene Techno Science Co Ltd, Ratios based on current share price

Gene Techno Science Co Ltd, Annual Ratios

Gene Techno Science Co Ltd, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List Of Figures, Charts and Diagrams
in Gene Techno Science Co Ltd (4584) - Financial and Strategic SWOT Analysis Review [Report Updated: 09-03-2018]

List of Figures


Gene Techno Science Co Ltd, Performance Chart

Gene Techno Science Co Ltd, Ratio Charts

Additional Details

Publisher

Global Data

Publisher Information

Reference

196387 | GDPH185545FSA

Number of Pages

25

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Gene Therapy Partnering Terms and Agreements 2010 to 2016
The Global Gene Therapy Partnering Agreements 2010-2016 report provides an understanding and access ...
01 Oct 2016 by Current Partnering USD $2,995 More Info
Oxford Gene Technology Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryOxford Gene Technology (OGT) is a biotechnology company that develops biomarkers. The company...
15 Mar 2016 by Global Data USD $250 More Info
Gene Techno Science Co., Ltd. (4584) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryGene Techno Science Co., Ltd. (GTS) is a biopharmaceutical company that develops and markets ...
10 Mar 2016 by Global Data USD $250 More Info
CRISPR/Cas 9 Gene Editing In Drug Discovery Trends 2016
HTStec's CRISPR/Cas 9 Gene Editing In Drug Discovery Trends 2016 report was published on 2 March 201...
02 Mar 2016 by HTStec USD $2,000 More Info
Oxford Gene Technology Limited - Medical Equipment - Deals and Alliances Profile
SummaryOxford Gene Technology (OGT) is a biotechnology company that develops biomarkers. The company...
25 Feb 2016 by Global Data USD $250 More Info
Da An Gene Co., Ltd. (002030) - Financial and Strategic SWOT Analysis Review
SummaryDa An Gene Co., Ltd. (Daan Gene) is a medical device company that offers molecular diagnostic...
09 Jan 2016 by Global Data USD $300 More Info
Da An Gene Co., Ltd. (002030) - Financial and Strategic SWOT Analysis Review
SummaryDa An Gene Co., Ltd. (Daan Gene) is a medical device company that offers molecular diagnostic...
08 Nov 2015 by Global Data USD $300 More Info
Oxford Gene Technology Limited - Medical Equipment - Deals and Alliances Profile
SummaryOxford Gene Technology (OGT) is a biotechnology company that develops biomarkers. The company...
23 Oct 2015 by Global Data USD $250 More Info
Physician Views: How comfortable are doctors with the commercial use of gene therapy?
Scope Gene therapy has been around for decades, yet in a sense the concept has recently been made to...
23 Mar 2015 by FirstWord Pharma USD $695 More Info
Physician Views: Are neurologists ready to embrace gene therapy?
Scope As recently noted by Forbes, the biotech bull market of 2013 has helped to revive an approach ...
11 Jun 2014 by FirstWord Pharma USD $695 More Info

This report is published by Global Data

Download Free Report Summary PDF

Gene Techno Science Co Ltd (4584) - Financial and Strategic SWOT Analysis Review [Report Updated: 09-03-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data